Preemptive rofecoxib and dexamethasone for prevention of pain and trismus following third molar surgery *

Objective The goal of this preliminary randomized prospective clinical trial was to compare the analgesic efficacy and the reduction in trismus of preoperative rofecoxib, intraoperative dexamethasone, and both rofecoxib and dexamethasone following third molar extraction surgery. Study design Thirty-five subjects requiring surgical removal of at least 1 partial bony impacted mandibular third molar were invited to participate in this double-blind and double-dummy placebo-controlled clinical trial. Subjects were randomly assigned into 1 of 4 treatment groups: (1) placebo po preoperatively and placebo IV intraoperatively; (2) rofecoxib 50 mg po preoperatively and placebo IV intraoperatively; (3) placebo po preoperatively and dexamethasone10 mg IV intraoperatively; and (4) rofecoxib 50 mg po preoperatively and dexamethasone 10 mg IV intraoperatively. Subjects completed a diary assessing postoperative pain onset and intensity using categorical and visual analogue scales. Interincisal opening was assessed 1, 2, 3, and 7 days postoperatively using a Therabite ruler. Results This randomized controlled clinical trial enrolled 35 subjects. Two subjects did not meet the inclusion criteria and 4 did not return completed diaries. The mean age of the remaining 29 subjects (11 males, 18 females) was 22.8 years (+/- 0.6 year). The active treatments tended to delay the need for initial pain medication. When compared to other active treatments and to placebo, the combination of preoperative rofecoxib and intraoperative dexamethasone significantly reduced initial pain intensity ( P < .05). Baseline interincisal opening was 52.6 mm (+/- 6.2). The greatest decrease in interincisal opening was 43.3% for the placebo group at 24 hours. Preoperative rofecoxib alone showed a decrease in interincisal opening of 42.3% ( P = ns) at 24 hours. Intraoperative dexamethasone alone showed a decrease in the interincisal opening of 24.1% of baseline ( P < .05 vs placebo). The group receiving the combination of rofecoxib and dexamethasone showed a decrease in interincisal opening of 23.7% of baseline ( P < .05 vs placebo). Conclusions The results of this trial indicate that the use of intraoperative dexamethasone is an effective therapeutic strategy for limiting trismus following surgical removal of impacted third molars. The combination of preoperative rofecoxib 50 mg and intraoperative dexamethasone 10 mg was most effective in minimizing pain and trismus following third molar surgery.     

Effect of evaporation of primer components on ultimate tensile strengths of primer-adhesive mixture.

OBJECTIVE: The purpose of the present study was to evaluate the effect of evaporation of primer components on the ultimate tensile strength (UTS) of primer-adhesive mixtures. METHODS: The UTSs of 1:3 by weight primer-adhesive mixtures and of the pure adhesives (controls) were measured after 0-, 2-, 5-min and 24-h storage in a 37 degrees C oven for the three-step etch&rinse adhesive OptiBond FL (Kerr) and the two-step self-etch adhesive Clearfil SE (Kuraray). RESULTS: Evaporation of primer components increased with time for both adhesives investigated. OptiBond FL showed a higher evaporation of primer components than Clearfil SE at the 2-, 5-min and 24-h storage time. As compared to the pure adhesive, the UTS of the primer-adhesive mixture was lower after 0- and 2-min storage for OptiBond FL and after 0-, 2- and 5-min storage for Clearfil SE. The UTS of OptiBond FL was higher than that of Clearfil SE at the 0- and 2-min storage time, though there was no difference at the 5-min and 24-h storage time. SIGNIFICANCE: The degree of evaporation of primer components depended largely on the primer solvents employed. The significant decrease in UTS of adhesive resin when mixed with primer must be attributed to incomplete evaporation of primer components. Complete evaporation of solvents is hard to achieve, even by thorough air drying.     

Advocacy training in US advanced pediatric dentistry training programs

PURPOSE: This study: (1) assessed pediatric dentistry residency program directors' attitudes toward and involvement in advocacy training; and (2) identified types and extent of advocacy training in U.S. pediatric dentistry programs. METHODS: Between October 2005 and February 2006, all 66 pediatric dentistry residency program directors were invited to complete a 62-item online questionnaire. The survey investigated: (1) directors' attitudes toward advocacy training; (2) nature of advocacy training offered during residency; (3) extent of resident involvement in different settings; and (4) directors' involvement in advocacy. RESULTS: Forty-two program directors responded (64%). Overall, respondents agreed that advocacy by pediatric dentists for children beyond the dental office was important and that residency programs should provide advocacy training. Most programs did not routinely offer advocacy opportunities in nonclinical settings. Over half of programs required community outreach clinic rotations for all residents. One third offered didactic curriculum in the legislative process. Over 50% of program directors reported personal involvement in legislative oral health lobbying within 3 years, but fewer than a third were involved with professional political action committees (PACs). CONCLUSIONS: Advocacy is seen as on important in pediatric dentistry but variation in attitudes of program directors and program offerings exists in US training programs.     

The effect of casting procedures on rotational misfit in castable abutments

PURPOSE: Misfit of implant components has been linked to restorative complications such as screw loosening. Although previous studies have shown a correlation between rotational misfit and screw loosening, the impact of casting procedures on rotational misfit is lacking. The aim of this in vitro study was to evaluate the effect of casting procedures on rotational misfit of cast abutments when compared to machined titanium abutments. MATERIALS AND METHODS: Forty-eight external hexagonal implants and 48 abutments were placed in 4 groups of 12 samples each: (1) machined titanium abutments, (2) premachined palladium abutments cast-on with palladium, (3) plastic burnout abutments cast with nickel chromium, and (4) plastic burnout abutments cast with cobalt chromium. Rotational misfit between the external hexagon of the implant and the internal hexagon of the abutment was measured using standardized techniques and recorded in degrees. Mean values for each group were analyzed with analysis of variance and Tukey test. RESULTS: The mean rotational misfit was 1.21 +/- 0.57 degrees for machined titanium abutments, 1.77 +/- 130 degrees for cast-on abutments, 1.98 +/- 0.72 degrees for cast NiCr abutments, and 2.79 +/- 1.13 degrees for cast CoCr abutments. Significantly greater rotational misfit was recorded with cast CoCr abutments when compared to machined titanium abutments (P < .05). CONCLUSION: Rotational misfit was less than 2 degrees for all groups except for cast CoCr abutments, which demonstrated a significantly greater rotational misfit.     

The osteoinductive potential of demineralized freeze-dried bone allograft in human non-orthotopic sites: a pilot study

BACKGROUND: The use of demineralized freeze-dried bone allograft (DFDBA) in periodontal therapy is widely accepted. In addition to histologic studies demonstrating its role in regenerating the attachment apparatus, its recognized ability to exhibit osteoinduction in small laboratory mammals has prompted many clinicians to regard it as osteoinductive when utilized in periodontal therapy. Despite such a theoretical deduction, evaluating and establishing the osteoinductive potential of DFDBA in humans has been problematic. The purpose of this study was to investigate, through the use of a novel implantation/recovery model, the potential of DFDBA to induce new bone formation at sites not normally considered capable of de novo osteogenic activity. METHODS: Seven patients scheduled to undergo periodontal therapy utilizing non-absorbable membranes agreed to have sterile polypropylene mesh capsules placed adjacent to the primary surgical site for the purpose of this investigation. One capsule was left empty while the second capsule contained DFDBA. At the appropriate time interval for removal of the therapeutic membrane, the capsules were removed and submitted for histologic analysis. Five of the subjects had procedures directed at regenerating bone within molar furcations (guided tissue regeneration) and had the membranes and associated capsules removed between 6 and 8 weeks. The 2 remaining patients had procedures directed toward ridge augmentation (guided bone regeneration) and had the membranes removed either at 8 or 9 months, respectively. In addition, one of the 2 long-term membrane patients had liberal cortical penetration performed directly beneath the implanted capsule. RESULTS: Histologic analysis of all recovered capsules by 2 independent oral and maxillofacial pathologists could not confirm the presence of either osteoblastic or osteoclastic activity associated with the DFDBA particles, although the 2 longer-term specimens clearly exhibited trace amounts of vital bone non-contiguous with the implanted material. CONCLUSIONS: The results of this pilot study do not support the osteoinductive potential of DFDBA when utilized in quantities normally associated with periodontal bone grafting, although they do support the use of this implantation/recovery model to study other preparations and mechanisms of bone formation.     

In-use peroxide kinetics of 10% hydrogen peroxide whitening strips

OBJECTIVE: Clinical research was conducted to establish the peroxide degradation profile of a very thin 10% hydrogen peroxide bleaching gel delivered on a flexible polyethylene strip. METHODS: Sixteen subjects participated in this study of Crest Whitestrips Premium, a thin layer of 10% hydrogen peroxide gel. Application was supervised, and strips were removed after five, 10, 30, and 60 minutes. Samples were collected from the strips, teeth, gingiva, and saliva, and peroxide levels were derived using a colorimetric peroxide assay. RESULTS: At five minutes, median peroxide concentrations were 7.3%, 6.4%, and 0.7% for strips, teeth, and gingiva, respectively, declining to 4.6%, 2.9%, and 0.1% at 30 minutes. Salivary samples never exceeded a median concentration of 0.014% at any time point. Samples differed significantly (p < 0.01) with respect to the 30- and 60-minute area-under-the-curve calculations, with the highest concentrations on the strip and teeth, and the lowest on the gingiva and in saliva. Median peroxide concentrations on strips and teeth remained above 2% over 60 minutes. At all post-treatment time points, the gingival peroxide concentration was an order of magnitude lower than the teeth samples. CONCLUSION: Use of 10% hydrogen peroxide whitening strips yielded appreciable peroxide on teeth over a 60-minute period, with rapid peroxide degradation on the gingiva, and exceedingly low accumulation in saliva anytime during use.     

Randomized controlled trial of 10% hydrogen peroxide whitening strips

OBJECTIVE: This research compared the clinical response of two different peroxide-containing gel formulations delivered using self-applied whitening strips. METHODOLOGY: A randomized, double-blind clinical trial was conducted to compare a one-week 10% hydrogen peroxide thin (0.13 mm) bleaching gel (Crest Whitestrips Premium) to a marketed two-week 6% hydrogen peroxide strip (0.20 mm) control (Crest Whitestrips). The maxillary arch was treated twice daily for 30 minutes. Efficacy (L*a*b* color change) was measured objectively by digital image analysis after one and two weeks. RESULTS: A total of 40 adults ranging from 19-48 years of age participated in the study. Both treatments were effective in whitening teeth, as evidenced by a statistically significant improvement from baseline (p < 0.001) beginning at one week. At that time, the adjusted mean deltab* (SE) (yellowness reduction) for the 10% strip was -2.42 (0.147) compared to -1.91 (0.143) for the 6% strip, with the treatments differing significantly (p = 0.02). At two weeks, the adjusted mean deltab* (SE) for the 10% strip was -3.31 (0.182) compared to -2.49 (0.167) for the control. After two weeks, treatments differed significantly (p < 0.02) for deltab* and deltaL* (lightness improvement). Comparing results from two weeks of the 6% control strip to one week of the 10% strip, the mean deltab* treatment difference was -0.07 (90% confidence interval from -0.44 to +0.31). Both treatments were generally well tolerated, with mild and transient tooth sensitivity or oral irritation representing the most common adverse events. CONCLUSION: Vital bleaching with 10% hydrogen peroxide strips at one week was as effective as 6% hydrogen peroxide strips used for two weeks.     

Effect of different application and polymerization techniques on the microleakage of proximal resin composite restorations in vitro

This in vitro study investigated cervical microleakage of proximal resin composite restorations placed with three application and polymerization techniques. Uniform mesio-occlusal-distal (MOD) preparations featuring cervical margins above (mesial) and below (distal) the CEJ suitable for restoration with resin composite were copy milled into 33 recently extracted permanent molars. The teeth were divided randomly into three groups of 11 teeth and restored using a conventional incremental technique (Group A) and two novel curing devices (Groups B and C). After 24 hours, a dye penetration test was used to assess microleakage. Conventional placement in preparations with cervical margins in enamel had significantly lower interfacial leakage scores than those recorded for placement in preparations with margins in cementum regardless of the technique used to place the restorative material. Use of the two novel curing devices conferred no advantage in reducing microleakage irrespective of where preparation margins were placed.     

Articaine hydrochloride: a safe alternative to lignocaine?

A focused literature search to appraise the safety and suitability of articaine as a substitute for lignocaine was conducted. An evidence-based approach to the current available literature suggests that articaine is an effective and well-tolerated anaesthetic for dental use. However, practitioners should be aware of a possible, as yet unproven, link between 4% concentrations of local anaesthetic solution and nerve damage. Clinical Relevance: The purpose of this paper is to share the findings of our focused literature review with general dental practitioners and outline the available evidence on the safety and use of articaine as a substitute for lignocaine.